MEDI-559

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
2013
UNLABELLED Despite substantial morbidity associated with respiratory syncytial virus (RSV) infection, there is no licensed… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
MEDI-559 is a recombinant live attenuated intranasal RSV vaccine candidate currently being evaluated in 5 to <24 month old RSV… (More)
Is this relevant?